Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health Outcomes
职业生涯中期指导奖,表彰以患者为导向的虚弱和健康结果研究
基本信息
- 批准号:10651807
- 负责人:
- 金额:$ 17.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcademyAccelerationAcuteAdoptedAdoptionAffectAgeAgingAwardCardiologyCaringClinicalClinical ManagementComplexDataData ScientistData SourcesDedicationsDiseaseElderlyEnvironmentEpidemiologistEpidemiologyFacultyFellowshipFosteringFundingFutureGeriatricsGoalsGrantGrowthHealthHealth PolicyHealth Services ResearchHealth StatusHealth systemHealthcare SystemsHeterogeneityIndividualInstitutionK-Series Research Career ProgramsLeadershipLearningLinkMeasurementMedicalMedicareMedicineMentorsMentorshipMethodologyMid-Career Clinical Scientist Award (K24)MissionNational Institute on AgingOperative Surgical ProceduresOutcomePaperPatientsPeer ReviewPersonsPharmacoepidemiologyPharmacotherapyPhysiologicalPilot ProjectsPopulationPostdoctoral FellowProliferatingPublic HealthPublishingReportingResearchResearch ActivityResearch MethodologyResearch PersonnelResearch Project GrantsResourcesStudentsSurgical SpecialtiesTrainingTraining ProgramsTranslatingWritingcareercareer developmentclinical decision-makingcollaborative environmentfeasibility testingfrailtyfunctional outcomeshuman old age (65+)implementation scienceimprovedindexingindividual patientinter-individual variationmedical specialtiesolder patientpatient oriented researchpersonalized carepersonalized medicineprimary care practiceprogramsresponsible research conductskillsstandard of carestressortreatment effecttreatment responsetrend
项目摘要
PROJECT SUMMARY
Increasing evidence suggests that frailty—a common problem of old age characterized by reduced physiologic
reserve and inability to tolerate acute stressors—may determine inter-individual variability in outcomes after drug
therapy and surgical procedures among older adults. While this understanding supports the idea of personalizing
treatments based on a patient's frailty level, there is little empirical evidence on how to use frailty information to
maximize benefits or avoid harms in older patients. There is a pressing need to understand how frailty affects
the outcomes of various medical and surgical treatments. The candidate is a geriatrician and epidemiologist
who has established a robust patient-oriented research program on frailty, geriatric pharmacoepidemiology, and
prediction of functional outcomes after surgery at Hebrew SeniorLife Marcus Institute for Aging Research. He is
also a dedicated mentor of trainees and junior faculty, who have published a number of peer-reviewed papers
and have successfully competed for training and career development awards in aging research. The candidate's
research program has a long-term objective to improve care of older adults with frailty by generating high-quality
evidence, training future clinicians and researchers, and changing health systems and policy. Toward this goal,
his current NIA-funded research focuses on use of a frailty index for Medicare data to determine who should be
treated with a drug therapy or a surgical procedure and who should not due to lack of benefit or increased
likelihood of harm. This K24 Mid-career Investigator Award proposal will allow the candidate to develop a formal
mentoring program, expand his research, and become a more effective mentor and leader. The specific aims
are to: 1) develop a mentoring program in frailty research for early-stage and new investigators from diverse
clinical and research backgrounds; 2) conduct high-quality research to determine heterogeneity of treatment
effects by frailty for a broad range of medical and surgical interventions; and 3) acquire new research skills in
implementation science and enhance capacity in mentorship and leadership within and outside geriatrics. The
outstanding collaborative environment of Hebrew SeniorLife and other Harvard-affiliated institutions will provide
resources (e.g., various data sources, including Medicare data, computing environment, and career development
training courses) and support (e.g., data scientists and research methodology experts) needed to accomplish
the proposed activities. The advancement of the candidate's mentoring and research program, supported by
this K24 award, will foster growth of well-trained clinician investigators in aging research and accelerate adoption
of personalized medicine for older adults across medical and surgical specialties based on a patient's frailty level.
项目概要
越来越多的证据表明,虚弱是老年人的一个常见问题,其特征是生理机能下降
储备和无法耐受急性应激源——可能决定药物治疗后结果的个体间差异
虽然这种理解支持个性化的想法。
治疗基于患者的虚弱程度,但很少有经验证据表明如何使用虚弱信息来治疗
迫切需要了解衰弱如何影响老年患者。
各种药物和手术治疗的结果。候选人是一位老年病学家和流行病学家。
他建立了一个强大的以患者为中心的研究计划,涉及虚弱、老年药物流行病学和
希伯来高级生命马库斯衰老研究所的手术后功能结果预测。
也是实习生和初级教师的忠实导师,他们发表了许多同行评审的论文
并成功角逐衰老研究方面的培训和职业发展奖项。
研究计划的长期目标是通过产生高质量的成果来改善对虚弱老年人的护理
证据,培训未来的支持者和研究人员,并改变卫生系统和政策以实现这一目标,
他目前由 NIA 资助的研究重点是使用医疗保险数据的虚弱指数来确定谁应该接受治疗
接受药物治疗或外科手术治疗且由于缺乏益处或增加而不应接受的人
K24 职业生涯中期研究员奖提案将允许候选人制定正式的损害可能性。
指导计划,扩大他的研究,并成为一个更有效的导师和领导者的具体目标。
目标是: 1) 为来自不同领域的早期和新研究人员制定衰弱研究指导计划
临床和研究背景;2)进行高质量的研究以确定治疗的异质性
虚弱对广泛的医疗和外科干预措施的影响;3) 获得以下领域的新研究技能:
实施科学并增强老年医学内外的指导和领导能力。
希伯来高级生活中心和其他哈佛附属机构的出色协作环境将提供
资源(例如各种数据源,包括医疗保险数据、计算环境和职业发展
培训课程)和完成所需的支持(例如数据科学家和研究方法专家)
候选人的指导和研究计划的进展,并得到支持。
该 K24 奖项将促进衰老研究领域训练有素的临床研究人员的成长并加速采用
根据患者的虚弱程度,跨医学和外科专业为老年人提供个性化医疗。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Assessment of Frailty Index at 66 Years of Age and Association With Age-Related Diseases, Disability, and Death Over 10 Years in Korea.
韩国 66 岁衰弱指数评估及其与年龄相关疾病、残疾和死亡的关联 10 多年。
- DOI:
- 发表时间:2023-03-01
- 期刊:
- 影响因子:13.8
- 作者:Jang, Jieun;Jung, Heewon;Shin, Jaeyong;Kim, Dae Hyun
- 通讯作者:Kim, Dae Hyun
Balancing Benefit and Harm of Intensive Blood Pressure Lowering Based on Individual Outcome Profile Analysis.
基于个体结果分析的强化降压的利弊平衡。
- DOI:
- 发表时间:2023-12
- 期刊:
- 影响因子:0
- 作者:Shi, Sandra M;Gouskova, Natalia;Park, Chan Mi;Travison, Thomas G;Wei, Lee;Kim, Dae Hyun
- 通讯作者:Kim, Dae Hyun
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dae Hyun Kim其他文献
Dae Hyun Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dae Hyun Kim', 18)}}的其他基金
Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health Outcomes
职业生涯中期指导奖,表彰以患者为导向的虚弱和健康结果研究
- 批准号:
10448534 - 财政年份:2022
- 资助金额:
$ 17.25万 - 项目类别:
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
应用基于索赔的衰弱指数为衰弱指导决策提供证据
- 批准号:
10297953 - 财政年份:2021
- 资助金额:
$ 17.25万 - 项目类别:
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
应用基于索赔的衰弱指数为衰弱指导决策提供证据
- 批准号:
10297953 - 财政年份:2021
- 资助金额:
$ 17.25万 - 项目类别:
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
应用基于索赔的衰弱指数为衰弱指导决策提供证据
- 批准号:
10640938 - 财政年份:2021
- 资助金额:
$ 17.25万 - 项目类别:
Prospective Monitoring of Newly Approved Cardiovascular Drugs in Older Adults with Frailty
新批准的心血管药物对虚弱老年人的前瞻性监测
- 批准号:
10338082 - 财政年份:2019
- 资助金额:
$ 17.25万 - 项目类别:
Epidemiology and Risk of Antipsychotic Use in Hospitalized Elderly with Delirium
患有谵妄的住院老年人的流行病学和使用抗精神病药物的风险
- 批准号:
9980746 - 财政年份:2018
- 资助金额:
$ 17.25万 - 项目类别:
Development and Validation of a Frailty Index Using Claims Data for Pharmacoepidemiologic Studies in Older Adults
使用老年人药物流行病学研究的索赔数据开发和验证虚弱指数
- 批准号:
8966383 - 财政年份:2015
- 资助金额:
$ 17.25万 - 项目类别:
相似国自然基金
基于增广拉格朗日函数的加速分裂算法及其应用研究
- 批准号:12371300
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
肠菌源性丁酸上调IL-22促进肠干细胞增殖加速放射性肠损伤修复的机制研究
- 批准号:82304065
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肌红蛋白构象及其氧化还原体系探究tt-DDE加速生鲜牛肉肉色劣变的分子机制
- 批准号:32372384
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于联邦学习自动超参调整的数据流通赋能加速研究
- 批准号:62302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
M2 TAMs分泌的OGT通过促进糖酵解过程加速肝细胞癌恶性生物学行为的机制研究
- 批准号:82360529
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
The Role of CD4+ Memory T cell Subtypes in Periodontal Disease Recurrence
CD4 记忆 T 细胞亚型在牙周病复发中的作用
- 批准号:
10642981 - 财政年份:2023
- 资助金额:
$ 17.25万 - 项目类别:
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
镰状细胞病的克隆造血和遗传变异
- 批准号:
10638404 - 财政年份:2023
- 资助金额:
$ 17.25万 - 项目类别:
Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocation
美国服务不足人群的流行病防范:利用 RADx-UP 联盟的数据评估用于资源分配的公共卫生工具
- 批准号:
10881319 - 财政年份:2023
- 资助金额:
$ 17.25万 - 项目类别:
Mechanisms underlying mustard gas-induced conjunctival injury and use of lipid mediators as medical countermeasures
芥子气引起的结膜损伤的机制以及脂质介质作为医疗对策的使用
- 批准号:
10882060 - 财政年份:2023
- 资助金额:
$ 17.25万 - 项目类别:
Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia
优化他非诺喹的剂量以根治东南亚间日疟原虫疟疾
- 批准号:
10703688 - 财政年份:2023
- 资助金额:
$ 17.25万 - 项目类别: